Freedom Leaf, Inc. Announces Launch of Leafceuticals, Inc., A
Wholly-Owned Division For The Research, Development, and
Distribution Of Superior Legal Hemp Products For The Hempology
Line
LAS VEGAS, NV--(NewMediaWire - Oct 10, 2017) - Freedom Leaf,
Inc. (OTCQB: FRLF), The Marijuana Legalization Company ™,
introduces Leafceuticals, Inc, a wholly owned division
dedicated to providing distribution, standardized formulations, and
consistent quality assurance for the natural whole-hemp
full-spectrum ingredients in
the Hempology brand product line and
possibly third party clients for private label. Leafceuticals will
also promote and manage sales of the NuAxon Tech line of
CO2 Supercritical Extractors and our Las Vegas based extraction
showroom facility.
Our lab-tested CBD oil in
the Hempology line contains >60% pure
full-spectrum CBD extract, which also includes cannabinoids like
CBG, CBN, and CBC for comprehensive health benefits. To maximize
effectiveness, additional therapeutic compounds like terpenes,
phenols, and flavonoids are added to provide the full entourage
effect. We utilize only the most beneficial supplements of 99% pure
CBD isolate to our top-of-the-line nutraceutical formulations. Our
natural CBD oil is produced from American-grown hemp crops and
extracted in modern processing facilities.
CEO and President Clifford J Perry stated,
"With LeafceuticalsInc.com and MyHempology.com we
are committed to enhancing human health and well-being by
manufacturing and marketing superior nutraceutical ingredients that
are positioned to excel in today's demanding marketplace. We
provide our customers with laboratory tested, non-gmo,
full-spectrum CBD products for the rapidly expanding legal hemp
industry. Our manufacturing facilities are FDA, GMP and PETA
registered. We are committed to producing the finest in breathable
vapors and topical blends from natural herbal and hemp
extracts."
Currently, we are in negotiations with multiple successful
marketers that service the niche hemp industry: smoke shops,
dispensaries, and natural health stores. We are also in serious
discussions with a national distributor that works with convenience
stores and big box chains, where we plan to open up new markets for
hemp products.
Additionally, the MyHempology.com website has an affiliate
marketing program to allow social media and other market
influencers to join in on spreading the news and sales globally.
Our Spanish affiliates, Freedom Leaf Iberia and Green Market
Europe, are also developing in-house sources of rare cannabinoids
for use in future Hempology products.
To help promote the Hempology and Leafceuticals brand
opportunities, Freedom Leaf, Inc. along with our Joint Venture
Investor Relations partner WallStreet Research™, LLC will be
making presentations at two major financial conferences in October,
at New West Summit Cannabis Tech Conference in Oakland
(Oct. 13, 14, 15) and at The Alternative Asset ReLeaf
Summit (Oct. 23) at the Wynn/Encore Hotel in Las Vegas,
Freedom Leaf's hometown.
See Freedom Leaf, Inc. and WallStreet Research LLC Joint
Venture To Become the Go-To Resource in the Marijuana/Hemp
Sector
About WallStreetResearch™
Alan Stone & Company, LLC with its affiliate
WallStreetResearch™ provides a strategic approach to enhancing
shareholder value and liquidity. WSR publishes and distributes
corporate profiles, newsletters and in-depth research reports on
emerging small-cap companies. WallStreetResearch™ is ranked #1 on
Google, Yahoo and Bing search engines.
(WSR) has also issued a research report on Freedom
Leaf Read the WSR Freedom Leaf Research
Report
About NuAxon Tech
NuAxon Tech is the manufacturer of large capacity CO2
Supercritical Extraction unit, and has 17 years of experience in
extraction process technology and manufacture of large capacity
extraction units over other comparable units, which will serve as a
huge plus for Freedom Leaf Inc.
According to NuAxon Tech, CO2 extraction is "the best method of
extracting therapeutic compounds from a plant. When CO2 is captured
and compressed it becomes a lipophilic solvent. It is exceptional
and efficient at retrieving the oils and fats from plants, some
herbal extractions are as concentrated as 250 to 1." With
proprietary "high flow rate pump" reducing processing time to "as
low as 90 minutes per batch," NuAxon's CO2 Supercritical Extraction
unit can deliver a much higher output than competitive brands.
Freedom Leaf, Inc. has the worldwide exclusive sales and marketing
agreement to represent the NuAxon Bioscience line of CO2 Extractors
for the cannabis and hemp industry, which include a 100 liter up to
1,000 liter capacity unit, the sizes that will be needed to convert
the thousands of acres of Hemp that are being planted in the U.S.
and around the world.
About Freedom Leaf
Freedom Leaf, Inc., The Marijuana Legalization Company™, is a
fully reporting and audited, publicly traded company trading under
the symbol (OTCQB: FRLF). Freedom Leaf, Inc. is a leading
go-to resource in the cannabis, medical marijuana, and industrial
hemp industry. It is involved in mergers and acquisitions and
business consulting in the marijuana industry, including
incubation/acceleration and spin offs of new marijuana/hemp related
companies.
Freedom Leaf, Inc.'s flagship publication
is Freedom Leaf Magazine, "The Good News in
Marijuana Reform". The company produces a portfolio of news, print
and digital multi-media verticals, websites, blogs and web
advertising, for the ever-changing emerging cannabis, medical
marijuana and industrial hemp industry.
Freedom Leaf, Inc. does not handle, grow, sell, or
dispense marijuana.
All of our European activities are in full compliance with relevant
EU laws.
Investor relations information can be found on
the FreedomLeafInc.com company website.
Safe Harbor Statement
Statements in this press release that are not strictly historical
are "forward-looking" statements within the meaning of Section 27A
of the Securities Act of 1933, as amended and Section 21E of the
Securities Exchange Act of 1934, as amended. These forward-looking
statements generally can be identified by phrases such as Freedom
Leaf, Inc. or its management "believes," "expects," "anticipates,"
"foresees," "forecasts," "estimates" or other words or phrases of
similar import. Similarly, statements herein that describe the
Company's business strategy, outlook, objectives, plans, intentions
or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Factors that could cause
or contribute to differences include the uncertainty regarding
viability and market acceptance of the Company's products and
services, changes in relationships with third parties, and other
factors described in the Company's most recent periodic filings
with the Securities and Exchange Commission, including its Annual
Report on Form 10-K dated June 30, 2016 and quarterly reports on
Form 10-Q.